Expert Panel Recommends Authorization of Pfizer’s COVID-19 Vaccine for Kids Aged 5-11

By Sam | October 26, 2021

Pfizer/BioNtech’s Emergency Use Authorization (EUA) application for a COVID-19 vaccine for young children has cleared its first regulatory hurdle.
Source: Drug Industry Daily

Posted in Drug Industry Daily